Breaking News
Top News
-
Sen. Warren slams Trump administration for pressuring EU to relax tech regulations
-
Volkswagen deal with EV maker Xpeng shows how China tech threatens Western automakers
-
Novo’s Wegovy cleared by UK drug price watchdog for heart disease, expanding access by 1.2 million people
-
Volkswagen deal with EV maker Xpeng shows how China tech threatens Western automakers
-
Weekly mortgage refinance demand is down more than 40% in the past month
-
Weekly mortgage refinance demand is down more than 40% in the past month
-
Oil supply crunch will worsen in April, IEA warns as it weighs releasing more strategic reserves
-
Oil supply crunch will worsen in April, IEA warns as it weighs releasing more strategic reserves
-
Stocks making the biggest moves premarket: Nike, RH, Sandisk & more
-
NFL approves sale of 3.5% of Las Vegas Raiders at over $11 billion valuation
-
Can a country get too rich?
-
“Liberation Day” has reshaped trade—but not as Donald Trump hoped
-
“Liberation Day” has reshaped trade—but not as Donald Trump hoped
-
Nike’s stock dives, as sales warning shows turnaround plan still isn’t working
-
Gold price today, Wednesday, April 1: Gold strengthens after Trump shares war exit timeline
-
Grindr Inc. (GRND) Bets on Monetization Over User Growth
-
Why Analysts Remain Bullish On Intuit Inc. (INTU)
-
Citizens Starts Netflix, Inc. (NFLX) Coverage, But Stays Cautious
-
Barclays Reaffirms Equal Weight Rating for uniQure (QURE)
-
Mineralys Therapeutics (MLYS) Garnering Attention With Lorundrostat Progress
2026-02-05


































